Peptide Literature Review Workflows: From Search Strategy to Reproducible Brief

A literature review becomes useful when another person can understand what was searched, what was excluded, how evidence was classified, and where uncertainty remains. For peptide programs, that structure helps teams avoid treating a review article, preclinical experiment, clinical trial, and market claim as interchangeable evidence.

A repeatable workflow

Write the question and inclusion rules first. Record databases, date searched, query strings, language limits, and duplicate handling. Screen titles and abstracts against the stated question, then extract study type, peptide identity, model or population, comparator, endpoint, exposure, result, and limitations. Preserve the article identifier and source URL so a reviewer can retrieve the underlying record.

Evidence tables should distinguish direct findings from inference. A cell-transport experiment may inform formulation hypotheses but does not establish human bioavailability. A registered trial may show that a study exists but not that its outcome is positive. A market forecast may describe demand but not clinical efficacy. This restraint makes the brief more decision-ready.

Staffing implications

Research assistants can execute documented searches, deduplicate citations, maintain screening logs, and assemble source packets. Subject-matter leads should approve inclusion logic and interpret findings. A lightweight review queue with due dates and named owners is often enough to keep recurring updates moving without losing provenance.

Scope note

This article describes evidence-synthesis practice and does not provide medical advice or a treatment recommendation.